FDA Inspection 1029902 — Continental Vitamin Company Inc

Continental Vitamin Company Inc — FEI 2016882

The FDA completed an inspection of Continental Vitamin Company Inc on Oct 26, 2017 in Vernon, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 26, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vernon, CA (United States)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
439121 CFR 211.180(e)(2)Items to cover on annual reviews